| Literature DB >> 16697205 |
Thomas J Styers1, Ahmet Kekec, Rodrigo Rodriguez, Joseph D Brown, Julia Cajica, Po-Shen Pan, Emily Parry, Chris L Carroll, Irene Medina, Ricardo Corral, Stephanie Lapera, Katerina Otrubova, Chung-Mao Pan, Kathleen L McGuire, Shelli R McAlpine.
Abstract
We report the synthesis of thirty-six Sansalvamide A derivatives, and their biological activity against colon cancer HT-29 cell line, a microsatellite stable (MSS) colon cancer cell-line. The thirty-six compounds can be divided into three subsets, where the first subset of compounds contains L-amino acids, the second subset contains D-amino acids, and the third subset contains both D- and L-amino acids. Five compounds exhibited excellent inhibitory activity (>75% inhibition). The structure-activity relationship (SAR) of the compounds established that a single D-amino acid in position 2 or 3 gave up to a 10-fold improved cytotoxicity over Sansalvamide A peptide. This work highlights the importance of residues 2 and 3 and the role of D-amino acids in the extraordinary SAR for this compound class.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16697205 DOI: 10.1016/j.bmc.2006.04.031
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641